Ignite Creation Date:
2024-05-06 @ 2:28 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02059213
Status:
COMPLETED
Last Update Posted:
2020-09-16
First Post:
2014-02-07
Brief Title:
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Organization Data
Organization:
University of Michigan Rogel Cancer Center
Class:
OTHER
Study ID:
UMCC 2013117
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Michigan Rogel Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Utah | OTHER |
| Vanderbilt-Ingram Cancer Center | OTHER |
| Johns Hopkins University | OTHER |
| Thomas Jefferson University | OTHER |
| Washington University School of Medicine | OTHER |
| Northwestern University | OTHER |
| City of Hope Comprehensive Cancer Center | OTHER |